Lobbying Activity Report

2606-31284

Organization: sanofi-aventis Canada Inc.
Was this lobbying activity a letter sent on behalf of one or more of the organizations listed as members of a coalition in your Registration Return? No
Associated registration: 8767-2606-18
Lobbying Activity date: 2023-12-13
Arranged a meeting: No
Posted date: 2023-12-14

In-house lobbyists who participated in the lobbying activity: Daniel Kennedy
Carrie McElroy
Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, Assistant Deputy Minister
Pharmaceutical, Laboratory & Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discuss BC PharmaCare and BC Ministry of Health Policy Initiatives and their impact on Sanofi in the province.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Negotiate the listing of Dupixent on the BC PharmaCare formulary
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Health
 
Senior officer who filed this Lobbying Activity Report: Stephanie Veyrun-Manetti
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Date Modified: